Trevena
TRVN
#11301
Rank
NZ$0.01 M
Marketcap
NZ$0.02138
Share price
0.00%
Change (1 day)
-38.81%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -NZ$49.98 Million

According to Trevena's latest financial reports the company's current earnings are NZ$0.54 Million. In 2023 the company made an earning of -NZ$64.74 Million, an increase over its 2022 earnings that were of -NZ$93.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$49.98 Million-22.8%
2023 -NZ$64.74 Million-30.69%
2022 -NZ$93.4 Million1.38%
2021 -NZ$92.13 Million78.04%
2020 -NZ$51.75 Million21.3%
2019 -NZ$42.66 Million-13.91%
2018 -NZ$49.56 Million-59.75%
2017 -NZ$0.13 Billion-31.77%
2016 -NZ$0.19 Billion101.73%
2015 -NZ$89.45 Million1.14%
2014 -NZ$88.44 Million114.83%
2013 -NZ$41.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$18.33 B-33,224.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B-24,861.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.15 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.6 Billion 2,778.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$18.34 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.12 Billion 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.12 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA